TotalMarketCap

Mustang Bio

MBIONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.986 M

$0.39 -5.24%

Close of 6 Nov 2026

As of 6 Nov 2026, Mustang Bio (MBIO) has a market capitalization of $2.99M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$1.92M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #46960 Degrees PharmaceuticalsSXTP$3.18M
  2. #470Ernexa TherapeuticsERNA$3.02M
  3. #471Mustang BioMBIO$2.99M
  4. #472Kala BioKALA$2.95M
  5. #473Clearmind MedicineCMND$2.90M

What if Mustang Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,726,408

Per share 9,457,888× higher

Bitcoin $1.53T

$201,629.44

Per share 511,750× higher

Apple $5.02T

$661,930.62

Per share 1,680,027× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Mustang Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.